The South American Glabellar Experience Study (SAGE): A Multicenter Retrospective Analysis of Real-World Treatment Patterns Following the Introduction of IncobotulinumtoxinA in Argentina: Banegas RA et al.

Abstract: Background: IncobotulinumtoxinA was approved in Argentina in 2007 for the treatment of moderate to severe glabellar lines. …

Aesthetic Surgery Journal XX(X) 1–7
DOI: 10.1177/1090820X13503475
 
Autoren:
Raúl A. Banegas, MD; Fernando Farache, MD; Alberto Rancati, MD, PhD; Myriam Chain, MD; Conor J. Gallagher, PhD; Mary Ann Chapman, PhD; and Carrie A. Caulkins, PhD
  
 
 
 
Autoren-Details:
Corresponding Author:
Dr Conor Gallagher, Director, Medical Affairs, Allergan, Inc, 2525Dupont Dr, Irvine, CA 92612, USA.E-mail: Gallagher_Conor@Allergan.com